Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb 26.
doi: 10.1186/s12879-026-12913-7. Online ahead of print.

Hepatitis delta virus co-infection in patients with hepatocellular carcinoma and people living with HIV in Nigeria

Ijeoma Ifeorah  1   2   3 , Birgit Bremer  4 , Yusuf Musa  5 , Julia Kahlhöfer  4   6   7 , Oluwatosin Oguntoye  8   9   10 , Carey Tishiya  11 , Gatuwa Aglavdawa  12 , Ojonuga Ameh  13 , Yussuf Abdulkadir  14 , Olumuyiwa Ariyo  8   9   10 , Manfred Anim  4   6 , Andre Reinhardt  15 , Albert Heim  16 , Uwem George  17 , Lukman Abdulkareem  8   13 , Ibrahim Umar Garzali  18 , Heiner Wedemeyer  4   6   7   19 , Lisa Sandmann  20   21   22
Affiliations
Free article

Hepatitis delta virus co-infection in patients with hepatocellular carcinoma and people living with HIV in Nigeria

Ijeoma Ifeorah et al. BMC Infect Dis. .
Free article
No abstract available

Keywords: Epidemiology; HDV; HIV/HBV co-infected; Hepatocellular Carcinoma; High-risk population; Nigeria.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Ethical approval was obtained from the institutional review boards (IRBs) of each participating hospital before patient recruitment (UATH/HREC/PR/2021/001/06, FMCNHREC.REG.N003/082012, AKTH/MAC/12A/P-3/V1/3170, ERC/2022/08–12/833A, NHREC/25/10/2013). Informed consent for study participation was obtained from all participants. The study was conducted in accordance with the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

References

    1. Hepatitis D. https://www.who.int/news-room/fact-sheets/detail/hepatitis-d. (Accessed. July 2, 2025).
    1. Stockdale AJ, Kreuels B, Henrion MYR, De C, Hutin Y, Geretti AM. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis The global prevalence of hepatitis D virus infection : Systematic review and meta-analysis. J Hepatol. 2020;73(3):523–32. https://doi.org/10.1016/j.jhep.2020.04.008.
    1. Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen-antibody system (δ/anti-δ) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18(12):997–1003. https://doi.org/10.1136/gut.18.12.997.
    1. Mentha N, Clément S, Negro F, Alfaiate D. A review on hepatitis D: From virology to new therapies. J Adv Res. 2019;17:3–15. https://doi.org/10.1016/j.jare.2019.03.009.
    1. Degasperi E, Sandmann L, Wedemeyer H, et al. Hepatitis D virus infection: pathophysiology, epidemiology and treatment. report from the third delta cure meeting 2024. Liver Int. 2025;45(7). https://doi.org/10.1111/liv.70189.

LinkOut - more resources